A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Trial of Perioperative Endocrine Therapy - Individualising Care

NCT02338310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Arimidex and Radiotherapy Sequencing

NCT01402193 ·Status: UNKNOWN ·Phase: PHASE3

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

NCT00237133 ·Status: COMPLETED ·Phase: PHASE4

Breast Cancer Tumor Care Observational Programme

NCT00660244 ·Status: COMPLETED

Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

NCT01300351 ·Status: COMPLETED ·Phase: PHASE3

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

NCT00975676 ·Status: COMPLETED ·Phase: NA

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

NCT00267553 ·Status: TERMINATED ·Phase: PHASE3

Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy

NCT06172088 ·Status: COMPLETED ·Phase: NA

OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)

NCT02335957 ·Status: COMPLETED ·Phase: NA

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

NCT00459771 ·Status: COMPLETED ·Phase: PHASE3

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

NCT02936206 ·Status: TERMINATED ·Phase: PHASE1

Aromatase Inhibitor Host Factors Study

NCT01669343 ·Status: COMPLETED ·Phase: NA

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00044291 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer

NCT02463032 ·Status: COMPLETED ·Phase: PHASE2

Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer

NCT02344940 ·Status: COMPLETED ·Phase: PHASE4

Quality Of Life While Receiving Faslodex

NCT00643513 ·Status: COMPLETED

Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.

NCT03236974 ·Status: COMPLETED ·Phase: PHASE1

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

NCT00050141 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00099437 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

NCT00921115 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg

NCT00305448 ·Status: COMPLETED ·Phase: PHASE2

Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users

NCT01579734 ·Status: UNKNOWN ·Phase: PHASE3

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

NCT00878930 ·Status: COMPLETED

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

NCT00259090 ·Status: COMPLETED ·Phase: PHASE2

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

NCT06440967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3